Hims peptide FDA rumors point to Category 1 push
TradeXchange Newsdesk reports social-media rumors that the FDA plans to move peptides, including BPC-157 and TB-500, to Category 1 before end of October; no confirmation or details were supplied.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
TradeXchange Newsdesk reports social-media rumors that the FDA plans to move peptides, including BPC-157 and TB-500, to Category 1 before end of October; no confirmation or details were supplied.